🇺🇸 FDA
Patent

US 8598321

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

granted A61PA61P31/04

Quick answer

US patent 8598321 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P31/04